BIOX — Bioceres Crop Solutions Income Statement
0.000.00%
Last trade - 00:00
- $935.97m
- $1.17bn
- $415.10m
- 95
- 36
- 58
- 68
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 160 | 172 | 207 | 328 | 415 |
Cost of Revenue | |||||
Gross Profit | 73.4 | 78.8 | 88.1 | 120 | 180 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 128 | 133 | 168 | 289 | 361 |
Operating Profit | 32.1 | 39.1 | 38.4 | 39.9 | 54.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.37 | 6.44 | 10.5 | 14.1 | 19.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.4 | 4.24 | -3.82 | -3.91 | 20.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -18.4 | 3.36 | -6.87 | -7.2 | 18.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.4 | 3.36 | -6.87 | -7.2 | 18.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.609 | 0.079 | -0.222 | -0.268 | 0.291 |